IRVINGTON, N.Y., July 3, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind ®, the FDA approved device for dermatologists in their fight against melanoma, today announced that it will be hosting a conference call to provide a business update to investors at 4:30 PM ET on July 11, 2013.
|Date:||Thursday, July 11, 2013|
|Time:||4:30 PM ET|
|To participate in the teleconference, please dial:|
|Domestic toll-free:||(877) 303-9205|
CONTACT: For Investors Lynn Pieper Westwicke Partners 415-202-5678 For Media Erica Sperling Rpr Marketing Communications 212.317.1462 firstname.lastname@example.org